论文部分内容阅读
目的对毒品案件样本进行N-甲基-3,4-亚甲二氧基卡西酮(bk-MDMA)确证检验。方法采用阴离子检测、颜色反应、气质联用(GC/MS)、核磁共振(NMR)、傅立叶变换红外光谱(FTIR)等方法对毒品案件中白色晶体样本进行剖析确证。结果快速筛查结果提示样本为具有亚甲二氧基结构的仲胺物质的盐酸盐,经GC/MS、NMR、FTIR检验,确证样本为bk-MDMA,系3,4-亚甲二氧基甲基苯丙胺(3,4-methylenedioxymethamphetmaine,MDMA)的卡西酮类似物。结论采用本文所用方法可以对毒品案件样本中N-甲基-3,4-亚甲二氧基卡西酮成分进行确证,该药具有滥用的可能性应引起相关部门的重视。
OBJECTIVE To confirm the bk-MDMA confirmatory test of drug cases by N-methyl-3,4-methylenedioxidocaine. Methods Anion detection, color reaction, gas chromatography-mass spectrometry (GC / MS), nuclear magnetic resonance (NMR) and Fourier transform infrared spectroscopy (FTIR) were used to analyze the white crystal samples in drug cases. Results The rapid screening results suggested that the sample was a hydrochloride of secondary amine with methylenedioxy structure. The samples were confirmed to be bk-MDMA by GC / MS, NMR and FTIR. Cathinone analogues of 3,4-methylenedioxymethamphetmaine (MDMA). Conclusion The method used in this article can confirm the N-methyl-3,4-methylenedioxidocaine ingredient in the drug case samples. The possibility of abuse of the drug should be given the attention of relevant departments.